Priscilla Zawislak

Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.

With ingredients sold to multiple markets, excipient manufacturers must understand the different regulatory requirements for pharma vs. food.

This article seeks to encourage continued dialogue among stakeholders to achieve consensus regarding excipient additives and processing aids.

Increasingly stringent audit requirements will make third-party accredited GMP audits critical for pharmaceutical excipients and raw materials.

This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.